Status:
COMPLETED
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Encephalitis, Tick-Borne
Eligibility:
All Genders
1-10 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the safety, immunogenicity and tolerability of TBE vaccines administered to children.
Eligibility Criteria
Inclusion
- Healthy male and female children, 1 to 10 years of age.
Exclusion
- Subjects with documented evidence of TBE
- Subjects, who have been previously vaccinated against TBE
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00311441
Start Date
March 1 2005
Last Update
March 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weilheim, Germany